623 related articles for article (PubMed ID: 36364178)
1. Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes.
Kaabi YA
Molecules; 2022 Oct; 27(21):. PubMed ID: 36364178
[TBL] [Abstract][Full Text] [Related]
2. Genetic Variants and Their Associations to Type 2 Diabetes Mellitus Complications in the United Arab Emirates.
ElHajj Chehadeh S; Sayed NS; Abdelsamad HS; Almahmeed W; Khandoker AH; Jelinek HF; Alsafar HS
Front Endocrinol (Lausanne); 2021; 12():751885. PubMed ID: 35069435
[TBL] [Abstract][Full Text] [Related]
3. Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy.
Preguiça I; Alves A; Nunes S; Gomes P; Fernandes R; Viana SD; Reis F
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31963709
[TBL] [Abstract][Full Text] [Related]
4. Contribution of hyperglycemia on diabetic complications in obese type 2 diabetic SDT fatty rats: effects of SGLT inhibitor phlorizin.
Katsuda Y; Sasase T; Tadaki H; Mera Y; Motohashi Y; Kemmochi Y; Toyoda K; Kakimoto K; Kume S; Ohta T
Exp Anim; 2015; 64(2):161-9. PubMed ID: 25736710
[TBL] [Abstract][Full Text] [Related]
5. Intrarenal arterial resistance is associated with microvascular complications in Chinese type 2 diabetic patients.
Liu KH; Chu WC; Kong AP; Ko GT; Ma RC; Chan JW; So WY; Luk AO; Cheung KK; Ozaki R; Ahuja AT; Chan JC
Nephrol Dial Transplant; 2013 Mar; 28(3):651-8. PubMed ID: 23223219
[TBL] [Abstract][Full Text] [Related]
6. Shared and specific biological signalling pathways for diabetic retinopathy, peripheral neuropathy and nephropathy by high-throughput sequencing analysis.
Hui Z; Chen YM; Gong WK; Lai JB; Yao BB; Zhao ZJ; Lu QK; Ye K; Ji LD; Xu J
Diab Vasc Dis Res; 2022; 19(4):14791641221122918. PubMed ID: 35989592
[TBL] [Abstract][Full Text] [Related]
7. Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury.
Yuchen C; Hejia Z; Fanke M; Qixin D; Liyang C; Xi G; Yanxia C; Xiongyi Y; Zhuohang X; Guoguo Y; Min F
Front Endocrinol (Lausanne); 2023; 14():1032015. PubMed ID: 36755923
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow-CNS connections: implications in the pathogenesis of diabetic retinopathy.
Yellowlees Douglas J; Bhatwadekar AD; Li Calzi S; Shaw LC; Carnegie D; Caballero S; Li Q; Stitt AW; Raizada MK; Grant MB
Prog Retin Eye Res; 2012 Sep; 31(5):481-94. PubMed ID: 22609081
[TBL] [Abstract][Full Text] [Related]
9. AMPK in microvascular complications of diabetes and the beneficial effects of AMPK activators from plants.
Shrikanth CB; Nandini CD
Phytomedicine; 2020 Jul; 73():152808. PubMed ID: 30935723
[TBL] [Abstract][Full Text] [Related]
10. How to prevent the microvascular complications of type 2 diabetes beyond glucose control.
Valencia WM; Florez H
BMJ; 2017 Jan; 356():i6505. PubMed ID: 28096078
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of inflammatory and vascular endothelial dysfunction biomarkers in microvascular and macrovascular complications in type 1 diabetes.
Wołoszyn-Durkiewicz A; Myśliwiec M
Pediatr Endocrinol Diabetes Metab; 2019; 25(1):28-35. PubMed ID: 31343130
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of VEGF inhibition in diabetic microvascular complications.
Tremolada G; Lattanzio R; Mazzolari G; Zerbini G
Am J Cardiovasc Drugs; 2007; 7(6):393-8. PubMed ID: 18076206
[TBL] [Abstract][Full Text] [Related]
13. The association of cell adhesion molecules and selectins (VCAM-1, ICAM-1, E-selectin, L-selectin, and P-selectin) with microvascular complications in patients with type 2 diabetes: A follow-up study.
Siddiqui K; George TP; Mujammami M; Isnani A; Alfadda AA
Front Endocrinol (Lausanne); 2023; 14():1072288. PubMed ID: 36843591
[TBL] [Abstract][Full Text] [Related]
14. Genetic associated complications of type 2 diabetes mellitus.
Wong YH; Wong SH; Wong XT; Yap QY; Yip KY; Wong LZ; Chellappan DK; Bhattamisra SK; Candasamy M
Panminerva Med; 2022 Jun; 64(2):274-288. PubMed ID: 34609116
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of microvascular complications in type 2 diabetes patients with the metabolic syndrome.
Abdul-Ghani M; Nawaf G; Nawaf F; Itzhak B; Minuchin O; Vardi P
Isr Med Assoc J; 2006 Jun; 8(6):378-82. PubMed ID: 16833164
[TBL] [Abstract][Full Text] [Related]
16. Effects of sarpogrelate on microvascular complications with type 2 diabetes.
Yoo H; Park I; Kim DJ; Lee S
Int J Clin Pharm; 2019 Apr; 41(2):563-573. PubMed ID: 30864083
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous microangiopathy in patients with type 2 diabetes: Impaired vascular endothelial growth factor expression and its correlation with neuropathy, retinopathy and nephropathy.
Sugimoto K; Murakami H; Deguchi T; Arimura A; Daimon M; Suzuki S; Shimbo T; Yagihashi S
J Diabetes Investig; 2019 Sep; 10(5):1318-1331. PubMed ID: 30719863
[TBL] [Abstract][Full Text] [Related]
18. Association Between Estimated Glomerular Filtration Rate and Microvascular Complications in Type II Diabetes Mellitus Patients: A 1-Year Cross-Sectional Study.
Babaliche P; Nadpara RA; Maldar A
J Natl Med Assoc; 2019 Feb; 111(1):83-87. PubMed ID: 30032867
[TBL] [Abstract][Full Text] [Related]
19. Association of non-alcoholic fatty liver disease with microvascular complications of type 2 diabetes.
Afarideh M; Aryan Z; Ghajar A; Ganji M; Ghaemi F; Saadat M; Heidari B; Mechanick JI; Esteghamati A
Prim Care Diabetes; 2019 Dec; 13(6):505-514. PubMed ID: 31054837
[TBL] [Abstract][Full Text] [Related]
20. The role of protein kinase C activation and the vascular complications of diabetes.
Das Evcimen N; King GL
Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
